30 Jan 2007 - LAB International Inc. announced it has closed the acquisition of all of the outstanding membership interests of PharmaForm L.L.C., a privately held company headquartered in Austin, Texas. U.S. $7.5 million in cash and U.S. $4.375 million in LAB shares have been paid at closing. The Sellers will be eligible for additional payments in LAB shares upon completion of certain milestones relating to PharmaForm's drug development programs reaching specific clinical trial stages.
 |
www.bionity.com/news/e/61335 |
|
 |
|
|
© Chemie.DE Information Service GmbH http://www.bionity.com/news/e/61335 |
Seydelstr. 28 · 10117 Berlin info@chemie.de · Tel: +49 (0)30 20 45 68 - 0 |